Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"I am genuinely very excited about the reduction in stage four cancers."
— Prof Charles Swanton , Academic
"Without mortality data and a transparent account of harms, claims of population benefit from multi-cancer early detection remain speculative."
— Prof Richard Houlston , Academic
Key People
Locations
All Coverage
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
Similar Stories
Related coverage based on topic and tags
GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
July 13, 2026 at 06:45 PMPeople in 50s urged to complete bowel cancer screening
Health officials warn little over half of 54-year-olds completed free at-home test kits.
July 11, 2026 at 03:03 AMGSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters
July 10, 2026 at 01:46 PM'Endometriosis tests would have given me years back'
It has been announced that two new rapid tests for the condition will be made available on the NHS.
July 11, 2026 at 06:29 AMEndometriosis groups 'crying out' for cut in diagnosis time
Two new non-invasive tests available from GPs are being proposed to speed up diagnosis times.
July 12, 2026 at 06:15 AMAstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports - Reuters
AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports Reuters
July 8, 2026 at 06:34 PM